Clementz and colleagues (2011) demonstrated NOTCH1 and NOTCH4 are transcriptionally activated by PEA3 in breast cancer cell lines, and knockdown of PEA3 or treatment with a GSI resulted in a G1 cell cycle arrest, increased apoptosis, and either treatment reduced tumor burden in mice [136]. Here, ETV4 is linked to breast cancer.